CalciMedica Inc CALC

Healthcare

CalciMedica, Inc. is a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium (CRAC) channel inhibition therapies for acute and chronic inflammatory and immunologic illnesses. The Company's technology targets the inhibition of CRAC channels to modulate the immune response and protect against tissue cell injury. Its lead product candidate is Auxora, a potent and selective intravenous (IV) formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys. The Company is conducting a Phase 2b trial (called CARPO - NCT04681066) for acute pancreatitis (AP) with systemic inflammatory response syndrome (SIRS), as well as supporting the ongoing Phase 1/2 asparaginase induced pancreatic toxicity (AIPT) study (called CRSPA - NCT04195347).

NDAQ:CALC - Post by User

CalciMedica Inc

<< Previous

Bullboard Posts

Next >>

Post by alphaflighton Nov 08, 2021 8:49am

570 Views

Post# 34098938

Graycliff Intersects 19.38 g/t Gold over 4.20 M in Hole 21

Graycliff Exploration Intersects High-Grade

Interval in Hole 21 of 19.38 g/t Gold over 4.20 Metres at Shakespeare Project, Ontario

TORONTO, ON – November 8, 2021 - Graycliff Exploration Limited (the “Company” or “Graycliff”) (CSE: GRAY) (OTCQB: GRYCF) (FSE: GE0) is pleased to announce additional assay results from drilling on its Shakespeare Gold Project located on the prolific Canadian Shield near Sudbury, Ontario. The final results are from the 2,200-metre Phase Two program that focused on defining the extent of gold mineralization proximal to the historic Miller Shaft where initial gold mining took place more than 100 years ago.

Drill Holes J-21-21 intersected a mineralized interval of 19.38 g/t gold (“Au”) over 4.20 metres, including 13.10 g/t Au over 1.0 m and 112.00 g/t over 0.60 metres. Significant intervals for holes J-18-21 to J-21-21 are detailed below:

Table 1 - Highlighted Results from Hole J-18-21 to J-21-21

President and CEO James Macintosh stated: “Drill hole J-21-21, which showed significant visible gold in the drill core, returned another great result that was also one of our deeper mineralized intersections in the first two phases. This continues to support our theory that the deposit is open at depth and along strike. Results for the Phase Two drilling are now complete, and we are shifting our focus to Phase Three, which has been underway since earlier this summer. We have now successfully extended our mineralized zone to a width of over 115 metres.”

Qualified Person

Bruce Durham, P.Geo, is a Qualified Person, as that term is defined by Canadian regulatory guidelines under NI 43-101, and has read and approved the technical information contained in this press release.

About Graycliff Exploration Limited.

Graycliff Exploration is a mineral exploration company focused on its 1,025 hectares of prospective ground, located roughly 80 kilometres west of Sudbury on the prolific Canadian Shield. The Company's Shakespeare Project consists of one crown patented lease, two crown leases and 40 claims on a property associated with the historic Shakespeare Gold Mine, which operated from 1903 to 1907. Graycliff’s Baldwin Project is adjacent to the east and is comprised of 68 claims covering 1,500 hectares. This brings our total land package in the area to 2,525 hectares.